|
Name |
xylarenone A, (rel)-
|
| Molecular Formula | C15H20O4 | |
| IUPAC Name* |
(1aR,4R,7S,7aR,7bR)-4-hydroxy-1a-(3-hydroxyprop-1-en-2-yl)-7,7a-dimethyl-5,6,7,7b-tetrahydro-4H-naphtho[1,2-b]oxiren-2-one
|
|
| SMILES |
C[C@H]1CC[C@H](C2=CC(=O)[C@]3([C@@H]([C@]12C)O3)C(=C)CO)O
|
|
| InChI |
InChI=1S/C15H20O4/c1-8-4-5-11(17)10-6-12(18)15(9(2)7-16)13(19-15)14(8,10)3/h6,8,11,13,16-17H,2,4-5,7H2,1,3H3/t8-,11+,13+,14+,15-/m0/s1
|
|
| InChIKey |
PSGJCHLXOJTCGB-SXHPEXCUSA-N
|
|
| Synonyms |
xylarenone A, (rel)-; Xylarenone A; CHEBI:69731; CHEMBL1813182; Q27138076; (1aR,4R,7S,7aR,7bR)-4-hydroxy-1a-(3-hydroxyprop-1-en-2-yl)-7,7a-dimethyl-5,6,7,7b-tetrahydro-4H-naphtho[1,2-b]oxiren-2-one
|
|
| CAS | NA | |
| PubChem CID | 24752810 | |
| ChEMBL ID | CHEMBL1813182 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 264.32 | ALogp: | 0.7 |
| HBD: | 2 | HBA: | 4 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 70.1 | Aromatic Rings: | 3 |
| Heavy Atoms: | 19 | QED Weighted: | 0.584 |
| Caco-2 Permeability: | -4.754 | MDCK Permeability: | 0.00002870 |
| Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.002 |
| Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.427 |
| 30% Bioavailability (F30%): | 0.006 |
| Blood-Brain-Barrier Penetration (BBB): | 0.933 | Plasma Protein Binding (PPB): | 37.84% |
| Volume Distribution (VD): | 0.588 | Fu: | 74.06% |
| CYP1A2-inhibitor: | 0.011 | CYP1A2-substrate: | 0.818 |
| CYP2C19-inhibitor: | 0.016 | CYP2C19-substrate: | 0.812 |
| CYP2C9-inhibitor: | 0.006 | CYP2C9-substrate: | 0.035 |
| CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.211 |
| CYP3A4-inhibitor: | 0.021 | CYP3A4-substrate: | 0.516 |
| Clearance (CL): | 4.181 | Half-life (T1/2): | 0.949 |
| hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.22 |
| Drug-inuced Liver Injury (DILI): | 0.19 | AMES Toxicity: | 0.973 |
| Rat Oral Acute Toxicity: | 0.857 | Maximum Recommended Daily Dose: | 0.433 |
| Skin Sensitization: | 0.745 | Carcinogencity: | 0.323 |
| Eye Corrosion: | 0.146 | Eye Irritation: | 0.554 |
| Respiratory Toxicity: | 0.834 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005060 | ![]() |
0.578 | D08PIQ | ![]() |
0.265 | ||
| ENC002770 | ![]() |
0.506 | D07DVK | ![]() |
0.260 | ||
| ENC002779 | ![]() |
0.495 | D03IKT | ![]() |
0.260 | ||
| ENC002780 | ![]() |
0.484 | D0CW1P | ![]() |
0.260 | ||
| ENC004560 | ![]() |
0.342 | D0IT2G | ![]() |
0.260 | ||
| ENC004555 | ![]() |
0.338 | D0D1SG | ![]() |
0.258 | ||
| ENC004784 | ![]() |
0.313 | D0KR5B | ![]() |
0.258 | ||
| ENC005062 | ![]() |
0.311 | D04VIS | ![]() |
0.253 | ||
| ENC001526 | ![]() |
0.297 | D0I5DS | ![]() |
0.253 | ||
| ENC003344 | ![]() |
0.294 | D0R7JT | ![]() |
0.253 | ||